Review Article
Nanofibers Offer Alternative Ways to the Treatment of Skin Infections
Table 1
Molecules and organisms encapsulated into electrospun nanofibers.
| Encapsulated molecules | Polymer/polymer blends | Reference |
| Antibiotics | | | Rifampin | PLLA | [81] | Doxorubicin hydrochloride | PLLA | [81] | Paclitaxil | PLLA | [81] | Tetracycline hydrochloride | PEVA | [60] | Mefoxin | PLGA/PEG-b-PLLA | [82] |
| Plasmid DNA | | | pCMVb encoding a -Galactosidase | PLGA and PLA-PEG | [83] |
| Growth Factors | | | Human -nerve growth factor (NGF) | PCLEEP | [54] | Human glialcell-derived neurotrophic factor (GDNF) | PCLEEP | [84] | Bone morfogenetic protein-2 (BMP-2) | PLGA-Hap | [85] |
| Antimicrobial compounds | | | Silver nanoparticles | Cellulose acetate | [72] | PCL/silver-loaded zirconium phosphate | [86] |
| Proteins | | | BSA | PEO | [87] | Lysozyme | PCL/PEO | [53] | Lysozyme | PCL/PEG | [77] | Cytochrome C | PLLA/PLL | [61] |
| Bacteria | | | Eschericia coli | | | Staphylococcus albus | PVA | [88] | Micrococcus luteus | | | Eschericia coli | PEO | [89] | Lactobacillus plantarum | PEO | [90] |
| Bacteriophages | | | T7 | | | T4 | | | | PVA | [88] | M13 | PVP | [91] |
|
|
PLLA: poly (L-lactide); PEVA: poly-ethylene-co-vinyl acetate; PLGA: poly-lactate-co-glycolide; PEG: polyethylene glycol; PLGA/PEG-b-PLLA: poly-lactate-co-glycolide/polyethylene glycol-block-poly(L lactide); PCL: poly ε-caprolactone; PCLEEP: poly ε-caprolactone ethyl ethylene phosphate; Hap: Hydroxyapatite; PEO: polyethylene oxide; PDLA: poly(D,L-lactide); PLL: poly(L-lysine); PVA: poly(vinyl alcohol); PVP: polyvinylpyrrolidone.
|